Chart Analysis: Get Key Insights on Global Blood Therapeutics, Inc. (GBT)

Global Blood Therapeutics, Inc. (GBT) has seen some recent activity in the marketplace and its common shares finished trading at $56.36 yesterday. Investors are starting to take notice of GBT as the common shares traded as high as $56.76 and as low as $55.35 in the last market day.

Global Blood Therapeutics, Inc. (GBT) average trading volume is 767.26K. However, in the last market day Global Blood Therapeutics, Inc. (GBT) exchanged 594,878 shares. The 1st downside support level on GBT is $52.88 and the 1st resistance level on GBT is $81.82. GBT 50 day moving average is $57.35 and GBT 200 day moving average is $65.79.

Global Blood Therapeutics, Inc. (GBT) recent performance has been specified by the recent movement in GBT common shares. GBT has performed 5.64% over the past 30 days, GBT has performed -20.33% over the past quarter and GBT has shown 16.11% over the past 12 months. Global Blood Therapeutics, Inc. (GBT) has a 52 week range of $39.95 to $87.54. Global Blood Therapeutics, Inc. (GBT) is trading 41.08% from its 52 week low and -35.62% from its 52 week high. Global Blood Therapeutics, Inc. (GBT) is indicating a 17.03% short float indicating the amount short in the float.

GBT has 61.12M shares outstanding and 54.44M shares in the float. Global Blood Therapeutics, Inc. (GBT) presently has a market cap of $3.47B and income of -286.40M. The EPS next quarter for GBT is -0.73 and anticipated EPS next year is 62.20%. The market cap of Global Blood Therapeutics, Inc. (GBT) at $3.47B signifies how many Investors own shares of GBT and is based off the last price ($56.36) of GBT and the amount of shares outstanding (61.12M) with Global Blood Therapeutics, Inc. (GBT).

Global Blood Therapeutics, Inc. (GBT) has total cash (mrq) of 540.73M, total cash per share (mrq) of 8.81, total debt of GBT rests at 159.16M and total debt/equity (mrq) is 32.10. . Global Blood Therapeutics, Inc. (GBT) operating cash flow (ttm) is -242.27M, GBT leveraged free cash flow (ttm) is -153.55M.

GBT is trading -4.56% below (bearish) its SMA20, -4.85% below (bearish) its SMA50 and -14.01% below (bearish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...